APO Research
Talk to an analyst

APO RESEARCH · REPORT

SPECT and PET Radiopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global SPECT and PET Radiopharmaceuticals Market Analysis and Forecast 2026-2032

23 December 2025194 pages

Choose your research edition.

Industry ResearchSPECT and PET Radiopharmaceuticals Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal SPECT and PET Radiopharmaceuticals Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal SPECT and PET Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SPECT and PET Radiopharmaceuticals Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal SPECT and PET Radiopharmaceuticals Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global SPECT and PET Radiopharmaceuticals market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for SPECT and PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for SPECT and PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for SPECT and PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for SPECT and PET Radiopharmaceuticals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of SPECT and PET Radiopharmaceuticals include China Isotope & Radiation, Novartis, Eli Lilly, Dongcheng, Bayer, SIEMENS, Mundipharma, Lantheus and Jubilant Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for SPECT and PET Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of SPECT and PET Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for SPECT and PET Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the SPECT and PET Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global SPECT and PET Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for SPECT and PET Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

SPECT and PET Radiopharmaceuticals Segment by Company

China Isotope & Radiation

Novartis

Eli Lilly

Dongcheng

Bayer

SIEMENS

Mundipharma

Lantheus

Jubilant Pharma

GE Healthcare

Curium Pharma

Cardinal Health

Bracco Imaging

Aurobindo Pharma

SPECT and PET Radiopharmaceuticals Segment by Type

Diagnostic Radiopharmaceuticals

Therapeutic Radiopharmaceuticals

SPECT and PET Radiopharmaceuticals Segment by Application

Hospitals

Clinics

Others

SPECT and PET Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SPECT and PET Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SPECT and PET Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SPECT and PET Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of SPECT and PET Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of SPECT and PET Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SPECT and PET Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diagnostic Radiopharmaceuticals Major Manufacturers Table 3. Therapeutic Radiopharmaceuticals Major Manufacturers Table 4. Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. SPECT and PET Radiopharmaceuticals Industry Trends Table 9. SPECT and PET Radiopharmaceuticals Industry Drivers Table 10. SPECT and PET Radiopharmaceuticals Industry Opportunities and Challenges Table 11. SPECT and PET Radiopharmaceuticals Industry Restraints Table 12. Global SPECT and PET Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global SPECT and PET Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 14. Global SPECT and PET Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 15. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 16. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 17. Global SPECT and PET Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global SPECT and PET Radiopharmaceuticals Sales by Region (2021-2026) & (k units) Table 19. Global SPECT and PET Radiopharmaceuticals Sales by Region (2027-2032) & (k units) Table 20. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 21. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2027-2032) Table 22. Global SPECT and PET Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 24. Global SPECT and PET Radiopharmaceuticals Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026) Table 26. Global SPECT and PET Radiopharmaceuticals Sales Price (USD/unit) of Manufacturers (2021-2026) Table 27. Global SPECT and PET Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global SPECT and PET Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global SPECT and PET Radiopharmaceuticals Manufacturers, Product Type & Application Table 30. Global SPECT and PET Radiopharmaceuticals Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global SPECT and PET Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global SPECT and PET Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 35. Global SPECT and PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 36. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 37. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 38. Global SPECT and PET Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 40. Global SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 41. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 42. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 43. Global SPECT and PET Radiopharmaceuticals Price by Type (2021-2026) & (USD/unit) Table 44. Global SPECT and PET Radiopharmaceuticals Price by Type (2027-2032) & (USD/unit) Table 45. Global SPECT and PET Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 47. Global SPECT and PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 48. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 49. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 50. Global SPECT and PET Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 52. Global SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 53. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 54. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 55. Global SPECT and PET Radiopharmaceuticals Price by Application (2021-2026) & (USD/unit) Table 56. Global SPECT and PET Radiopharmaceuticals Price by Application (2027-2032) & (USD/unit) Table 57. China Isotope & Radiation Company Information Table 58. China Isotope & Radiation Business Overview Table 59. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Portfolio Table 61. China Isotope & Radiation Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. Novartis SPECT and PET Radiopharmaceuticals Product Portfolio Table 66. Novartis Recent Development Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Eli Lilly SPECT and PET Radiopharmaceuticals Product Portfolio Table 71. Eli Lilly Recent Development Table 72. Dongcheng Company Information Table 73. Dongcheng Business Overview Table 74. Dongcheng SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Dongcheng SPECT and PET Radiopharmaceuticals Product Portfolio Table 76. Dongcheng Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Bayer SPECT and PET Radiopharmaceuticals Product Portfolio Table 81. Bayer Recent Development Table 82. SIEMENS Company Information Table 83. SIEMENS Business Overview Table 84. SIEMENS SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. SIEMENS SPECT and PET Radiopharmaceuticals Product Portfolio Table 86. SIEMENS Recent Development Table 87. Mundipharma Company Information Table 88. Mundipharma Business Overview Table 89. Mundipharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Mundipharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 91. Mundipharma Recent Development Table 92. Lantheus Company Information Table 93. Lantheus Business Overview Table 94. Lantheus SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Lantheus SPECT and PET Radiopharmaceuticals Product Portfolio Table 96. Lantheus Recent Development Table 97. Jubilant Pharma Company Information Table 98. Jubilant Pharma Business Overview Table 99. Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Jubilant Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 101. Jubilant Pharma Recent Development Table 102. GE Healthcare Company Information Table 103. GE Healthcare Business Overview Table 104. GE Healthcare SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. GE Healthcare SPECT and PET Radiopharmaceuticals Product Portfolio Table 106. GE Healthcare Recent Development Table 107. Curium Pharma Company Information Table 108. Curium Pharma Business Overview Table 109. Curium Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Curium Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 111. Curium Pharma Recent Development Table 112. Cardinal Health Company Information Table 113. Cardinal Health Business Overview Table 114. Cardinal Health SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Cardinal Health SPECT and PET Radiopharmaceuticals Product Portfolio Table 116. Cardinal Health Recent Development Table 117. Bracco Imaging Company Information Table 118. Bracco Imaging Business Overview Table 119. Bracco Imaging SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Bracco Imaging SPECT and PET Radiopharmaceuticals Product Portfolio Table 121. Bracco Imaging Recent Development Table 122. Aurobindo Pharma Company Information Table 123. Aurobindo Pharma Business Overview Table 124. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 126. Aurobindo Pharma Recent Development Table 127. North America SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 128. North America SPECT and PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 129. North America SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 130. North America SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 131. North America SPECT and PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (USD/unit) Table 132. North America SPECT and PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (USD/unit) Table 133. North America SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 134. North America SPECT and PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 135. North America SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 136. North America SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 137. North America SPECT and PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (USD/unit) Table 138. North America SPECT and PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (USD/unit) Table 139. North America SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. North America SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. North America SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 143. North America SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 144. North America SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 145. North America SPECT and PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (USD/unit) Table 146. North America SPECT and PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (USD/unit) Table 147. United States SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 148. Canada SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 149. Mexico SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 150. Europe SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 151. Europe SPECT and PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 152. Europe SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 153. Europe SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 154. Europe SPECT and PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (USD/unit) Table 155. Europe SPECT and PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (USD/unit) Table 156. Europe SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 157. Europe SPECT and PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 158. Europe SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 159. Europe SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 160. Europe SPECT and PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (USD/unit) Table 161. Europe SPECT and PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (USD/unit) Table 162. Europe SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Europe SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 166. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 167. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 168. Europe SPECT and PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (USD/unit) Table 169. Europe SPECT and PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (USD/unit) Table 170. Germany SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 171. France SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 172. U.K. SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 173. Italy SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 174. Russia SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 175. Spain SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 176. Netherlands SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 177. Switzerland SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 178. Sweden SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 179. Poland SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 180. China SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 181. China SPECT and PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 182. China SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 183. China SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 184. China SPECT and PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (USD/unit) Table 185. China SPECT and PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (USD/unit) Table 186. China SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 187. China SPECT and PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 188. China SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 189. China SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 190. China SPECT and PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (USD/unit) Table 191. China SPECT and PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (USD/unit) Table 192. Asia SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 193. Asia SPECT and PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 194. Asia SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 195. Asia SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 196. Asia SPECT and PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (USD/unit) Table 197. Asia SPECT and PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (USD/unit) Table 198. Asia SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia SPECT and PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 201. Asia SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 202. Asia SPECT and PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (USD/unit) Table 203. Asia SPECT and PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (USD/unit) Table 204. Asia SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Asia SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Asia SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. Asia SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 209. Asia SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 210. Asia SPECT and PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (USD/unit) Table 211. Asia SPECT and PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (USD/unit) Table 212. Japan SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 213. South Korea SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 214. India SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 215. Australia SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 216. Taiwan SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 217. Southeast Asia SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 218. SAMEA SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 219. SAMEA SPECT and PET Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 220. SAMEA SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 221. SAMEA SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 222. SAMEA SPECT and PET Radiopharmaceuticals Sales Price by Type (2021-2026) & (USD/unit) Table 223. SAMEA SPECT and PET Radiopharmaceuticals Sales Price by Type (2027-2032) & (USD/unit) Table 224. SAMEA SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA SPECT and PET Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 227. SAMEA SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 228. SAMEA SPECT and PET Radiopharmaceuticals Sales Price by Application (2021-2026) & (USD/unit) Table 229. SAMEA SPECT and PET Radiopharmaceuticals Sales Price by Application (2027-2032) & (USD/unit) Table 230. SAMEA SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. SAMEA SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. SAMEA SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. SAMEA SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 234. SAMEA SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 235. SAMEA SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 236. SAMEA SPECT and PET Radiopharmaceuticals Sales Price by Country (2021-2026) & (USD/unit) Table 237. SAMEA SPECT and PET Radiopharmaceuticals Sales Price by Country (2027-2032) & (USD/unit) Table 238. Brazil SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 239. Argentina SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 240. Chile SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 241. Colombia SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 242. Peru SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 243. Saudi Arabia SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 244. Israel SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 245. UAE SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 246. Turkey SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 247. Iran SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 248. Egypt SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 249. Key Raw Materials Table 250. Raw Materials Key Suppliers Table 251. SPECT and PET Radiopharmaceuticals Distributors List Table 252. SPECT and PET Radiopharmaceuticals Customers List Table 253. Research Programs/Design for This Report Table 254. Authors List of This Report Table 255. Secondary Sources Table 256. Primary Sources List of Figures Figure 1. SPECT and PET Radiopharmaceuticals Image Figure 2. Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SPECT and PET Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diagnostic Radiopharmaceuticals Image Figure 5. Therapeutic Radiopharmaceuticals Image Figure 6. Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global SPECT and PET Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global SPECT and PET Radiopharmaceuticals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 13. Global SPECT and PET Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2021-2032) Figure 16. Global SPECT and PET Radiopharmaceuticals Sales (2021-2032) & (k units) Figure 17. Global SPECT and PET Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico SPECT and PET Radiopharmaceuticals Sales YoY (2021-2032) & (k units) Figure 20. Europe SPECT and PET Radiopharmaceuticals Sales YoY (2021-2032) & (k units) Figure 21. China SPECT and PET Radiopharmaceuticals Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) SPECT and PET Radiopharmaceuticals Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales YoY (2021-2032) & (k units) Figure 24. Global SPECT and PET Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global SPECT and PET Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 30. Global SPECT and PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 33. Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 36. Global SPECT and PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 39. North America SPECT and PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 40. North America SPECT and PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 41. North America SPECT and PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 42. North America SPECT and PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 43. North America SPECT and PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 44. North America SPECT and PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 45. Europe SPECT and PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 46. Europe SPECT and PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 47. Europe SPECT and PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 48. Europe SPECT and PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 49. Europe SPECT and PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 50. Europe SPECT and PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 51. China SPECT and PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 52. China SPECT and PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 53. China SPECT and PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 54. China SPECT and PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 55. Asia SPECT and PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 56. Asia SPECT and PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 57. Asia SPECT and PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 58. Asia SPECT and PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 59. Asia SPECT and PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 60. Asia SPECT and PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 61. SAMEA SPECT and PET Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 62. SAMEA SPECT and PET Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 63. SAMEA SPECT and PET Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 64. SAMEA SPECT and PET Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 65. SAMEA SPECT and PET Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 66. SAMEA SPECT and PET Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 67. SPECT and PET Radiopharmaceuticals Value Chain Figure 68. Manufacturing Cost Structure Figure 69. SPECT and PET Radiopharmaceuticals Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • China Isotope & Radiation
  • Novartis
  • Eli Lilly
  • Dongcheng
  • Bayer
  • SIEMENS
  • Mundipharma
  • Lantheus
  • Jubilant Pharma
  • GE Healthcare
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 SPECT and PET Radiopharmaceuticals Market by Type
  3. 1.2.1 Global SPECT and PET Radiopharmaceuticals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostic Radiopharmaceuticals
  5. 1.2.3 Therapeutic Radiopharmaceuticals
  6. 1.3 SPECT and PET Radiopharmaceuticals Market by Application
  7. 1.3.1 Global SPECT and PET Radiopharmaceuticals Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 SPECT and PET Radiopharmaceuticals Market Dynamics
  1. 2.1 SPECT and PET Radiopharmaceuticals Industry Trends
  2. 2.2 SPECT and PET Radiopharmaceuticals Industry Drivers
  3. 2.3 SPECT and PET Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 SPECT and PET Radiopharmaceuticals Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global SPECT and PET Radiopharmaceuticals Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global SPECT and PET Radiopharmaceuticals Revenue by Region
  3. 3.2.1 Global SPECT and PET Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global SPECT and PET Radiopharmaceuticals Revenue by Region (2021-2026)
  5. 3.2.3 Global SPECT and PET Radiopharmaceuticals Revenue by Region (2027-2032)
  6. 3.2.4 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  7. 3.3 Global SPECT and PET Radiopharmaceuticals Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global SPECT and PET Radiopharmaceuticals Sales by Region
  9. 3.4.1 Global SPECT and PET Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global SPECT and PET Radiopharmaceuticals Sales by Region (2021-2026)
  11. 3.4.3 Global SPECT and PET Radiopharmaceuticals Sales by Region (2027-2032)
  12. 3.4.4 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global SPECT and PET Radiopharmaceuticals Revenue by Manufacturers
  2. 4.1.1 Global SPECT and PET Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global SPECT and PET Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global SPECT and PET Radiopharmaceuticals Sales by Manufacturers
  6. 4.2.1 Global SPECT and PET Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global SPECT and PET Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global SPECT and PET Radiopharmaceuticals Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global SPECT and PET Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global SPECT and PET Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global SPECT and PET Radiopharmaceuticals Manufacturers, Product Type & Application
  13. 4.7 Global SPECT and PET Radiopharmaceuticals Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global SPECT and PET Radiopharmaceuticals Market CR5 and HHI
  16. 4.8.2 2025 SPECT and PET Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
5 SPECT and PET Radiopharmaceuticals Market by Type
  1. 5.1 Global SPECT and PET Radiopharmaceuticals Revenue by Type
  2. 5.1.1 Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
  5. 5.2 Global SPECT and PET Radiopharmaceuticals Sales by Type
  6. 5.2.1 Global SPECT and PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global SPECT and PET Radiopharmaceuticals Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  9. 5.3 Global SPECT and PET Radiopharmaceuticals Price by Type
6 SPECT and PET Radiopharmaceuticals Market by Application
  1. 6.1 Global SPECT and PET Radiopharmaceuticals Revenue by Application
  2. 6.1.1 Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
  5. 6.2 Global SPECT and PET Radiopharmaceuticals Sales by Application
  6. 6.2.1 Global SPECT and PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global SPECT and PET Radiopharmaceuticals Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 6.3 Global SPECT and PET Radiopharmaceuticals Price by Application
7 Company Profiles
  1. 7.1 China Isotope & Radiation
  2. 7.1.1 China Isotope & Radiation Company Information
  3. 7.1.2 China Isotope & Radiation Business Overview
  4. 7.1.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Portfolio
  6. 7.1.5 China Isotope & Radiation Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis SPECT and PET Radiopharmaceuticals Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly SPECT and PET Radiopharmaceuticals Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Dongcheng
  20. 7.4.1 Dongcheng Company Information
  21. 7.4.2 Dongcheng Business Overview
  22. 7.4.3 Dongcheng SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Dongcheng SPECT and PET Radiopharmaceuticals Product Portfolio
  24. 7.4.5 Dongcheng Recent Developments
  25. 7.5 Bayer
  26. 7.5.1 Bayer Company Information
  27. 7.5.2 Bayer Business Overview
  28. 7.5.3 Bayer SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bayer SPECT and PET Radiopharmaceuticals Product Portfolio
  30. 7.5.5 Bayer Recent Developments
  31. 7.6 SIEMENS
  32. 7.6.1 SIEMENS Company Information
  33. 7.6.2 SIEMENS Business Overview
  34. 7.6.3 SIEMENS SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SIEMENS SPECT and PET Radiopharmaceuticals Product Portfolio
  36. 7.6.5 SIEMENS Recent Developments
  37. 7.7 Mundipharma
  38. 7.7.1 Mundipharma Company Information
  39. 7.7.2 Mundipharma Business Overview
  40. 7.7.3 Mundipharma SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mundipharma SPECT and PET Radiopharmaceuticals Product Portfolio
  42. 7.7.5 Mundipharma Recent Developments
  43. 7.8 Lantheus
  44. 7.8.1 Lantheus Company Information
  45. 7.8.2 Lantheus Business Overview
  46. 7.8.3 Lantheus SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lantheus SPECT and PET Radiopharmaceuticals Product Portfolio
  48. 7.8.5 Lantheus Recent Developments
  49. 7.9 Jubilant Pharma
  50. 7.9.1 Jubilant Pharma Company Information
  51. 7.9.2 Jubilant Pharma Business Overview
  52. 7.9.3 Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jubilant Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  54. 7.9.5 Jubilant Pharma Recent Developments
  55. 7.10 GE Healthcare
  56. 7.10.1 GE Healthcare Company Information
  57. 7.10.2 GE Healthcare Business Overview
  58. 7.10.3 GE Healthcare SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GE Healthcare SPECT and PET Radiopharmaceuticals Product Portfolio
  60. 7.10.5 GE Healthcare Recent Developments
  61. 7.11 Curium Pharma
  62. 7.11.1 Curium Pharma Company Information
  63. 7.11.2 Curium Pharma Business Overview
  64. 7.11.3 Curium Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Curium Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  66. 7.11.5 Curium Pharma Recent Developments
  67. 7.12 Cardinal Health
  68. 7.12.1 Cardinal Health Company Information
  69. 7.12.2 Cardinal Health Business Overview
  70. 7.12.3 Cardinal Health SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Cardinal Health SPECT and PET Radiopharmaceuticals Product Portfolio
  72. 7.12.5 Cardinal Health Recent Developments
  73. 7.13 Bracco Imaging
  74. 7.13.1 Bracco Imaging Company Information
  75. 7.13.2 Bracco Imaging Business Overview
  76. 7.13.3 Bracco Imaging SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bracco Imaging SPECT and PET Radiopharmaceuticals Product Portfolio
  78. 7.13.5 Bracco Imaging Recent Developments
  79. 7.14 Aurobindo Pharma
  80. 7.14.1 Aurobindo Pharma Company Information
  81. 7.14.2 Aurobindo Pharma Business Overview
  82. 7.14.3 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  84. 7.14.5 Aurobindo Pharma Recent Developments
8 North America
  1. 8.1 North America SPECT and PET Radiopharmaceuticals Market Size by Type
  2. 8.1.1 North America SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 8.1.2 North America SPECT and PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 8.1.3 North America SPECT and PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 8.2 North America SPECT and PET Radiopharmaceuticals Market Size by Application
  6. 8.2.1 North America SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 8.2.2 North America SPECT and PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 8.2.3 North America SPECT and PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 8.3 North America SPECT and PET Radiopharmaceuticals Market Size by Country
  10. 8.3.1 North America SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America SPECT and PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe SPECT and PET Radiopharmaceuticals Market Size by Type
  2. 9.1.1 Europe SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 9.1.2 Europe SPECT and PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 9.1.3 Europe SPECT and PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 9.2 Europe SPECT and PET Radiopharmaceuticals Market Size by Application
  6. 9.2.1 Europe SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 9.2.2 Europe SPECT and PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 9.2.3 Europe SPECT and PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 9.3 Europe SPECT and PET Radiopharmaceuticals Market Size by Country
  10. 9.3.1 Europe SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe SPECT and PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China SPECT and PET Radiopharmaceuticals Market Size by Type
  2. 10.1.1 China SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 10.1.2 China SPECT and PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 10.1.3 China SPECT and PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 10.2 China SPECT and PET Radiopharmaceuticals Market Size by Application
  6. 10.2.1 China SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 10.2.2 China SPECT and PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 10.2.3 China SPECT and PET Radiopharmaceuticals Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia SPECT and PET Radiopharmaceuticals Market Size by Type
  2. 11.1.1 Asia SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 11.1.2 Asia SPECT and PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 11.1.3 Asia SPECT and PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 11.2 Asia SPECT and PET Radiopharmaceuticals Market Size by Application
  6. 11.2.1 Asia SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 11.2.2 Asia SPECT and PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 11.2.3 Asia SPECT and PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 11.3 Asia SPECT and PET Radiopharmaceuticals Market Size by Country
  10. 11.3.1 Asia SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia SPECT and PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA SPECT and PET Radiopharmaceuticals Market Size by Type
  2. 12.1.1 SAMEA SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA SPECT and PET Radiopharmaceuticals Sales by Type (2021-2032)
  4. 12.1.3 SAMEA SPECT and PET Radiopharmaceuticals Price by Type (2021-2032)
  5. 12.2 SAMEA SPECT and PET Radiopharmaceuticals Market Size by Application
  6. 12.2.1 SAMEA SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA SPECT and PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 12.2.3 SAMEA SPECT and PET Radiopharmaceuticals Price by Application (2021-2032)
  9. 12.3 SAMEA SPECT and PET Radiopharmaceuticals Market Size by Country
  10. 12.3.1 SAMEA SPECT and PET Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA SPECT and PET Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA SPECT and PET Radiopharmaceuticals Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 SPECT and PET Radiopharmaceuticals Value Chain Analysis
  2. 13.1.1 SPECT and PET Radiopharmaceuticals Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 SPECT and PET Radiopharmaceuticals Production Mode & Process
  6. 13.2 SPECT and PET Radiopharmaceuticals Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 SPECT and PET Radiopharmaceuticals Distributors
  9. 13.2.3 SPECT and PET Radiopharmaceuticals Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst